Drug and Therapeutics Bulletin
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Aims and Scope
Drug and Therapeutics Bulletin is a monthly scientific journal with evaluations of, and practical advice on, individual treatments and the overall management of disease. The journal is published by the BMJ Group and as a founder member of The International Society of Drug Bulletins, the journal is also completely independent of the pharmaceutical industry, government and regulatory authorities, advertising and other forms of commercial sponsorship. Less
Key Metrics
Journal Specifications
- PublisherBMJ Publishing Group
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating Year-wise Publication
- 5Y
- 10Y
FAQs
What is the H-index. SNIP score, Citescore and SJR of Drug and Therapeutics Bulletin? 
Drug and Therapeutics Bulletin has a H-index score of 16, Citescore of 0.6, SNIP score of 0.24, & SJR of Q4
Who is the publisher of Drug and Therapeutics Bulletin?
The publisher of Drug and Therapeutics Bulletin is BMJ Publishing Group.
Where can I find a journal's aims and scope of Drug and Therapeutics Bulletin?
For the Drug and Therapeutics Bulletin's Aims and Scope, please refer to the section above on the page.
How can I view the journal metrics of Drug and Therapeutics Bulletin on editage?
For the Drug and Therapeutics Bulletin metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Drug and Therapeutics Bulletin?
The eISSN number is 1755-5248 and pISSN number is 0012-6543 for Drug and Therapeutics Bulletin.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Scopolamine, Osteoporosis, Preeclampsia, Aspirin, Heart failure, Hemodialysis, Type 2 diabetes, Empagliflozin, Large vessel vasculitis, Immune checkpoint inhibitors, Elevated serum alkaline phosphatase, Digitalis Toxicity, Quinidine, Risperidone, Observational study, Chloramphenicol eye drops, Systematic review, Randomized controlled trial, Renal tubular acidosis, Type 2 Diabetes Mellitus.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.